Grandis JR - Search Results

1

Stat3 activation in prostatic carcinomas.

Dhir R, Ni Z, Lou W, DeMiguel F, Grandis JR, Gao AC. Dhir R, et al. Among authors: grandis jr. Prostate. 2002 Jun 1;51(4):241-6. doi: 10.1002/pros.10079. Prostate. 2002. PMID: 11987152

2

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.

Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy DJ. Grandis JR, et al. J Clin Invest. 1998 Oct 1;102(7):1385-92. doi: 10.1172/JCI3785. J Clin Invest. 1998. PMID: 9769331 Free PMC article.

3

Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD. Grandis JR, et al. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4227-32. doi: 10.1073/pnas.97.8.4227. Proc Natl Acad Sci U S A. 2000. PMID: 10760290 Free PMC article.

4

STAT signaling in head and neck cancer.

Song JI, Grandis JR. Song JI, et al. Among authors: grandis jr. Oncogene. 2000 May 15;19(21):2489-95. doi: 10.1038/sj.onc.1203483. Oncogene. 2000. PMID: 10851047 Review.

5

Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.

Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR. Song JI, et al. Among authors: grandis jr. Cancer Res. 2001 Aug 1;61(15):5919-25. Cancer Res. 2001. PMID: 11479234

6

Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma.

Ni Z, Lou W, Lee SO, Dhir R, DeMiguel F, Grandis JR, Gao AC. Ni Z, et al. Among authors: grandis jr. J Urol. 2002 Apr;167(4):1859-62. J Urol. 2002. PMID: 11912448

7

Differential function of STAT5 isoforms in head and neck cancer growth control.

Leong PL, Xi S, Drenning SD, Dyer KF, Wentzel AL, Lerner EC, Smithgall TE, Grandis JR. Leong PL, et al. Among authors: grandis jr. Oncogene. 2002 Apr 25;21(18):2846-53. doi: 10.1038/sj.onc.1205385. Oncogene. 2002. PMID: 11973644

8

STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.

Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR. Kijima T, et al. Among authors: grandis jr. Cell Growth Differ. 2002 Aug;13(8):355-62. Cell Growth Differ. 2002. PMID: 12193474

9

Lack of toxicity of EGFR antisense gene therapy.

Zeng Q, Kanter PM, Dhir R, Gooding WE, Huang L, Grandis JR. Zeng Q, et al. Among authors: grandis jr. J Exp Ther Oncol. 2002 May-Jun;2(3):174-86. doi: 10.1046/j.1359-4117.2002.01033.x. J Exp Ther Oncol. 2002. PMID: 12415634

10

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth.

Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, Robbins PD, Gadiparthi S, Burke NA, Watkins SF, Grandis JR. Leong PL, et al. Among authors: grandis jr. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4138-43. doi: 10.1073/pnas.0534764100. Epub 2003 Mar 14. Proc Natl Acad Sci U S A. 2003. PMID: 12640143 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page